Banner

Earnings and Investment

>

Latest News

GE HealthCare reports first quarter results: ©Eagle - stock.adobe.com
GE HealthCare reports first quarter growth, updates full-year outlook amid trade headwinds

April 30th 2025

GE HealthCare showcases strong Q1 earnings with revenue growth, strategic acquisitions, and new product launches, despite adjusting full-year guidance due to tariffs.

Cirtec Medical expanding operations in Costa Rica: ©Cirtec Medical
Cirtec Medical continues investment in Costa Rica with major expansion of medical device manufacturing operations

April 24th 2025

RenovoRx increases production of RenovoCath: ©Wrightstudio - stock.adobe.com
RenovoRx increases production of RenovoCath device to meet growing demand

April 16th 2025

J&J reports positive results: ©Yanina - stock.adobe.com
Johnson & Johnson’s MedTech Division posts solid Q1 growth

April 15th 2025

The Trump tariff induced stock market downturn: What investors should keep in mind
The Trump tariff induced stock market downturn: What investors should keep in mind

April 8th 2025

More News

NeuroOne announces public offering, speeds up timeline for its trigeminal nerve ablation system

NeuroOne announces public offering, speeds up timeline for its trigeminal nerve ablation system

Medical Economics Staff
April 4th 2025

The company also expects to submit its application for 510(k) clearance for its OneRF Trigeminal Nerve Ablation System in May, sooner than expected.

VIPs touring SHL Medical's new South Carolina plant: ©SHL Medical

SHL Medical opens state-of-the-art manufacturing facility in South Carolina

Todd Shryock
April 3rd 2025

Swiss-based company’s plant will increase capacity to meet demand for autoinjectors

Boston Scientific closes Bolt Medical acquisition, bolsters intravascular lithotripsy portfolio

Boston Scientific closes Bolt Medical acquisition, bolsters intravascular lithotripsy portfolio

Medical Economics Staff
April 2nd 2025

Under the terms, Boston Scientific will pay about $443 million upfront, plus up to $221 million if regulatory milestones occur.

MicroTransponder secures $65 million to expand stroke recovery therapy: ©MicroTransponder

MicroTransponder secures $65 million to expand stroke recovery therapy

Todd Shryock
March 18th 2025

Investment will support the expansion of its FDA-approved therapy designed to improve upper extremity function in chronic ischemic stroke survivors.